<GlossaryTerm id="CDR0000546733"><TermName>CDK inhibitor AT7519M</TermName><TermPronunciation>(... in-HIH-bih-ter ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called AT7519M.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718788" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CDK inhibitor AT7519M&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718789" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de CDK AT7519M&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de CDK AT7519M</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. El inhibidor de CDK AT7519M bloquea unas enzimas necesarias para la división celular. Es un tipo de inhibidor de cinasas dependientes de ciclinas. También se llama AT7519M.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-05-04</DateFirstPublished></GlossaryTerm>
